Metabolic-Fit / 100
TMates review
Compounded semaglutide at $249 a month and tirzepatide at $297, held flat across every dose from the starting 0.25 mg all the way to the top of the ladder — and, unusually, priced identically whether you take it as an injection or an oral. TMates publishes its full commitment ladder up front rather than revealing it at checkout: three, six and twelve-month terms at $217, $175 and $158 a month for semaglutide and $267, $217 and $167 for tirzepatide, each shown with the total you actually pay. Every advertised saving checks out against the month-to-month rate. What it does not publish anywhere is the list of states it serves, so you cannot confirm availability before starting.
- HSA / FSA-eligible
- Editor-vetted
- No insurance needed
Elena Voss is a mother writing for mothers, not a treating clinician, and holds no medical license. Every clinical figure in this piece is cited inline to its primary source — the trial or the FDA label — so you can open it and check us. This is background reading, not medical advice.
TMates at a glance
- Semaglutide
- $249/mo
- Tirzepatide
- $297/mo
- Coverage
- Not published
- Brand-name
- Compounded only
How we scored TMates
Every factor comes from TMates's own published pricing, disclosures and oversight, and the six combine into the 54/100 Metabolic-Fit Score by the same weighted six-factor framework we apply to every provider — never nudged by whether a provider pays us.
No postpartum or breastfeeding framing — a generic weight program.
Thin on the hormonal picture that drives many mothers' weight.
Oversight and lab support fall short of the top of this roster — the review below says exactly where.
Cost is unpredictable or sits at the premium end.
Support is thin once the prescription ships.
Exit terms are the weak point: lock-in, notice periods, or a cancellation you have to chase.
How we verified this review
- Last verified
- August 2026
- Confidence
- medium
- Primary source
- tmates.com
$249 a month for semaglutide and $297 for tirzepatide are the month-to-month rates; the cheaper figures you will see — down to $158 and $167 — are twelve months paid up front, $1,900 and $1,999 in a single charge. TMates publishes no list of the states it serves, so availability stays unknown until you start.
What to expect when you sign up
We walked TMates's public signup funnel (August 2026) — a first-hand look at the flow. We don't create accounts, enter medical data, or complete checkout, so this is what any visitor sees, not a patient outcome.
- 1The signup call to action stays on tmates.com (https://tmates.com/shop)
What we noticed
- No monthly price is visible on the public homepage; the number appears only after you begin the intake
Pricing
Prices re-verified
| Medication | Monthly | Plan |
|---|---|---|
| Compounded semaglutide | $249 | Flat across every dose, injectable or oral |
| Compounded tirzepatide | $297 | Flat across every dose, injectable or oral |
Swipe the table to see plan details →
Many HSA and FSA plans cover GLP-1 telehealth — check yours. These figures are what TMates's own site disclosed at last review; this market re-prices often, so confirm the current number at the source.
What we like
- One price per molecule across every dose, so titrating up never raises the bill
- Oral and injectable cost exactly the same, which is rare and removes a hidden penalty for choosing the pill
- Publishes the full three, six and twelve-month ladder with the real totals, not just a per-month figure
- Every advertised discount reconciles against the month-to-month rate when you check the arithmetic
The caveats
- Publishes no list of the states it serves, so availability is unknown until you start
- The longer terms are prepaid commitments, so the cheapest per-month numbers are not month-to-month prices
- No postpartum, breastfeeding or PCOS guidance published anywhere on the site
TMates for mothers: our verdict
Compounded semaglutide at $249 a month and tirzepatide at $297, held flat across every dose from the starting 0.25 mg all the way to the top of the ladder — and, unusually, priced identically whether you take it as an injection or an oral. TMates publishes its full commitment ladder up front rather than revealing it at checkout: three, six and twelve-month terms at $217, $175 and $158 a month for semaglutide and $267, $217 and $167 for tirzepatide, each shown with the total you actually pay. Every advertised saving checks out against the month-to-month rate. What it does not publish anywhere is the list of states it serves, so you cannot confirm availability before starting. It runs about $249/month, flat across every dose — a premium to the category, so the extras have to earn it.
We weigh TMates the way mothers actually have to: not just the monthly cost, but postpartum and breastfeeding timing and PCOS and insulin resistance — the parts a general weight-loss roundup leaves out.
What TMates costs, in full
- Compounded semaglutide — Flat across every dose, injectable or oral: $249/mo
- Compounded tirzepatide — Flat across every dose, injectable or oral: $297/mo
For context, the typical ongoing price across our roster is around $179/month, so TMates sits at the premium end.
TMates says the price covers the provider visit and the medication. That is the comparison that matters at this price: two providers a few dollars apart can differ by a hundred a month once the extras are counted, so line up what each one bundles before you decide.
The medications TMates prescribes
TMates prescribes semaglutide and tirzepatide — the two with the largest published weight-loss effects, and carrying both on one account matters when insulin resistance, common with PCOS and after gestational diabetes, makes tirzepatide the better-suited option. These are compounded formulations from a licensed pharmacy — the reason the price stays down — but compounded GLP-1s aren't FDA-approved finished products the way Wegovy and Zepbound are.
A needle-free oral or sublingual option is on the menu, which draws in mothers who've been avoiding injections — just set expectations: oral and buccal delivery of these peptides is far less studied than the injectable versions the trials used.
Where TMates fits — and where it doesn't — for mothers
A good fit if…
- switching between semaglutide and tirzepatide may become necessary as your body and your hormones change.
Look elsewhere if…
- you specifically want an FDA-approved brand pen with its own pregnancy and lactation labeling.
- you want frictionless cancellation — read the cancellation and refund terms in the caveats above before you pay.
- you'd rather a prescriber talk through timing around postpartum and breastfeeding timing — that is the ground our #1 pick, CoreAge Rx, is built on.
Oversight, safety, and what we could verify
Our confidence is moderate — the core facts check out, but some details (per-state availability, program mechanics) aren't fully public. As with any compounded GLP-1, the most useful thing mothers can do is confirm which licensed pharmacy fills the prescription and what's in the formulation — we explain how we weigh oversight in our scoring methodology.
A standing caveat for mothers: GLP-1 medications aren't established as safe during pregnancy or breastfeeding, and every label advises against use. Nothing here changes that — plan the timing with your own clinician.
The bottom line
TMates is a reasonable option — weigh it on postpartum and breastfeeding timing and PCOS and insulin resistance against the alternatives below. For most mothers, CoreAge Rx remains the stronger all-round fit — see why it tops our ranking.
The bottom line for mothers
Best for: Someone who wants the dose ladder to stop mattering to the bill and prefers the commitment terms disclosed before checkout.
Alternatives to TMates
Providers we have a referral relationship with, ordered by their Metabolic-Fit Score — highest first. This module leaves out the provider whose page you are reading, so on CoreAge Rx's own review our #1 pick is the one name you will not find here. These are not the whole roster: see the full ranking for every provider we cover, paid or not.
- Visit CoreAge Rx92
Metabolic-Fit / 100
CoreAge RxOur #1 pickOne flat price, both molecules on a single chart, and a prescriber who reads your history before writing — the most predictable place for a mother to start and, just as important, to pause.
- Visit Gala Health84
Metabolic-Fit / 100
A flat $179 for either molecule with a genuinely gentle microdosing tier — a reasonable, all-doses-included option if you can live with a yearly plan and a pharmacy it doesn't name.
- Visit Enhance MD81
Metabolic-Fit / 100
One of the more oversight-forward compounded programs here — lab work and a live provider visit bundled into every plan, with a gentle microdosing tier — the catch is that the low '$212' headline you'll see quoted is the 12-month prepay rate, not the $249 you'd pay month to month.
Keep comparing TMates
Head-to-head & alternatives
TMates, answered
- How much does TMates cost?
- At last review, TMates's lowest ongoing compounded rate was about $249 a month — $249/mo for semaglutide, $297/mo for tirzepatide. This market re-prices often, so check the current all-in figure at the source before committing.
- Is TMates safe to use while breastfeeding?
- Nothing in this class — compounded or brand — has been established as safe in pregnancy or lactation, and every label advises against use. TMates is not an exception to that. Plan a GLP-1 for after weaning and settle the timing with your own clinician.
- Does TMates offer both semaglutide and tirzepatide?
- Yes — TMates offers both molecules. Tirzepatide's dual GIP/GLP-1 action is often preferred where insulin resistance drives weight, which matters for PCOS and after gestational diabetes.
- Where does TMates rank for mothers?
- TMates scores 54/100 on our Metabolic-Fit Score and sits at #52. That score is a weighted read of six things mothers actually have to care about. CoreAge Rx currently leads it — see how they compare.
Pricing, states and verification reflect TMates's public disclosures at last review; the Metabolic-Fit Score is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.